-
Posted by
Two Blokes April 23, 2025 -
Filed in
Stock
-
20 views
Denmark-based pharmaceutical giant Novo Nordisk (NVO 2.66%) has been struggling during the past year. Its financial results -- though strong by comparison to most of its peers -- haven't been as good as investors expected.
